Neurochem Gets 2nd Approvable For Kiacta; Analysts Pessimistic July 19, 2007 By Trista Morrison Almost a year after Neurochem Inc. received its first approvable letter for Kiacta (eprodisate) in the treatment of AA amyloidosis, history repeated itself. (BioWorld Today)Read More
RSS